Clinical Trials Logo

Vascular Surgery clinical trials

View clinical trials related to Vascular Surgery.

Filter by:

NCT ID: NCT03681834 Not yet recruiting - Vascular Surgery Clinical Trials

Multi-center Register for the Use of the Cor-Knot® Automated Knotting System in Heart Valve Surgery

RECORVA
Start date: September 2018
Phase:
Study type: Observational

The Cor-Knot® device is an automated knotting system for valve sutures and prosthetic rings used for more than a year during valve replacements and annuloplasties in cardiac surgery. It reduces the time spent knotting the threads fixing the prosthesis and thus reduces aortic clamping and extracorporeal circulation times. The originality of the project is based on the absence of national multi-rate data collection on the effectiveness and safety of the Cor-Knot® knotting device.

NCT ID: NCT03215446 Completed - Vascular Surgery Clinical Trials

Evaluate the Muscle Protection Effect of Sevoflurane Sedation in Vascular Surgery

PHAR
Start date: June 13, 2016
Phase: Phase 4
Study type: Interventional

Halogenated anaesthetic agents (HAA) may induce protective processes by pre-conditioning the myocardium. All of the literature shows that HAA induce pre-conditioning, thanks to a class effect, and Sevoflurane is the most widely used today. In humans, the protective effects of halogenated agents have principally been studied in heart surgery and have shown encouraging clinical results. It seems that HAA induce both pre-conditioning of the myocardium (early and late) and post conditioning. Given these protective effects of HAA, in 2007, the American Heart Association (AHA) recommended the use of HAA for anaesthesia maintenance in non-cardiac surgery in patients with a high cardio-vascular risk. The aim of this study is to show a decrease in rhabdomyolysis and tissue distress (kidneys, myocardium and liver), thanks to Sevoflurane anaesthesia, in the post-operative period following vascular surgery with clamping

NCT ID: NCT02863250 Recruiting - Trauma Clinical Trials

Australian and New Zealand Massive Transfusion Registry

ANZ-MTR
Start date: March 2011
Phase:
Study type: Observational [Patient Registry]

Severe and un-stopped blood loss can occur for a number of different reasons including after a serious injury, delivery of a baby and following other medical and surgical emergencies. The investigators understanding of how to best treat people with serious bleeding is still incomplete, with many questions remaining. These include questions regarding how many people have serious bleeding events, what happens to them and the best way to treat them. The Massive Transfusion Registry (MTR) is a register of patients who have experienced major blood loss that required a massive transfusion in any clinical setting. The MTR uses electronic data extraction and data linkage methodologies. Pre-existing clinical data from hospital data sources, including Laboratory Information Systems (for transfusion history and laboratory results) and Health Information Services databases (for Patient demographics and admission data), are electronically extracted by staff employed at the participating hospitals. The data is then sent to the MTR Research Team, located at Monash University, where it is then linked, analysed and stored. The establishment of a Massive Transfusion Registry will be a unique and important resource for clinicians in Australia, New Zealand and internationally, for Blood Services and for the broader community. It will provide valuable observational data regarding the types and frequency of conditions associated with critical bleeding requiring massive transfusion, the use of blood component therapy (i.e. ratios and quantities of different types of red cell to non- red cell components) and patient outcomes.

NCT ID: NCT02254642 Terminated - Vascular Surgery Clinical Trials

Effects of Ischemic Preconditioning After Aortic Clamping

Start date: November 20, 2018
Phase: N/A
Study type: Interventional

Open surgery for aneurysmal aortic disease can lead to cardiac, renal, pulmonary or muscular complications, essentially due to the aortic clamping. Ischemic preconditioning can be useful in order to decrease these complications. The investigators would like to use an ischemic preconditioning protocol during open surgery of aortic aneurysm in order to decrease these complications.

NCT ID: NCT01897519 Terminated - Vascular Surgery Clinical Trials

A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Surgery

Start date: May 2013
Phase: Phase 2
Study type: Interventional

This study will evaluate the safety and efficacy of ABT-719 in patients undergoing high risk major surgery.

NCT ID: NCT01558596 Active, not recruiting - Clinical trials for Peripheral Arterial Disease

Remote Ischemic Preconditioning Prior to Vascular Surgery

CRIPES
Start date: September 2011
Phase: Phase 1/Phase 2
Study type: Interventional

The investigators have previously shown that elective vascular surgery is a high-risk operation with an anticipated risk of either death or heart attack of 15%. This study is testing whether a protocol of remote ischemic preconditioning (RIPC) applied 24 hours prior to the operation is safe, feasible and reduces the incidence of an adverse, perioperative cardiac complication.

NCT ID: NCT00873704 Completed - Clinical trials for Surgical Wound Infection

Supplemental Oxygen in Vascular Surgery

Start date: March 2009
Phase: N/A
Study type: Interventional

The purpose of this study was to test the hypothesis that supplemental postoperative oxygen reduces the risk of surgical wound infection in patients following lower limb vascular surgery.

NCT ID: NCT00712023 Completed - Hypothermia Clinical Trials

Effect of Forced-air Warming and Circulating-water Mattress in Preventing Heat Loss During Vascular Surgery

Start date: July 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether a custom-made forced-air warming mattress can prevent heat loss in patients undergoing vascular surgery better than a circulating-water mattress

NCT ID: NCT00610545 Completed - Vascular Surgery Clinical Trials

Atorvastatin in Perioperative Vascular Surgery - Pilot Study

APVS
Start date: July 2007
Phase: Phase 4
Study type: Interventional

This study is designed to determine if the use of atorvastatin (Lipitor), a member of the HMG coA reductase inhibitor class of drugs referred to as statins, will reduce cardiovascular outcomes ( mortality - myocardial infarction - stroke ) when given in high doses in comparative standard doses in the perioperative period of major vascular surgery. Abdominal aortic aneurysm , Carotid endarterectomy , Revascularization of lower limbs

NCT ID: NCT00491608 Completed - Spinal Surgery Clinical Trials

Immunogenicity and Safety Study of Topical Recombinant Thrombin in Surgical Hemostasis

Start date: June 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and immune system response to recombinant thrombin when used to control bleeding in spinal and vascular surgery.